BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paolicchi E, Gemignani F, Krstic-Demonacos M, Dedhar S, Mutti L, Landi S. Targeting hypoxic response for cancer therapy. Oncotarget 2016;7:13464-78. [PMID: 26859576 DOI: 10.18632/oncotarget.7229] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 12.6] [Reference Citation Analysis]
Number Citing Articles
1 Wu J, Hong Y, Wu T, Wang J, Chen X, Wang Z, Cheng B, Xia J. Stromal-epithelial lactate shuttle induced by tumor‑derived interleukin‑1β promotes cell proliferation in oral squamous cell carcinoma. Int J Mol Med 2018;41:687-96. [PMID: 29207019 DOI: 10.3892/ijmm.2017.3267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
2 Mutti L, Peikert T, Robinson BWS, Scherpereel A, Tsao AS, de Perrot M, Woodard GA, Jablons DM, Wiens J, Hirsch FR, Yang H, Carbone M, Thomas A, Hassan R. Scientific Advances and New Frontiers in Mesothelioma Therapeutics. J Thorac Oncol 2018;13:1269-83. [PMID: 29966799 DOI: 10.1016/j.jtho.2018.06.011] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 18.3] [Reference Citation Analysis]
3 Ciardiello C, Leone A, Budillon A. The Crosstalk between Cancer Stem Cells and Microenvironment Is Critical for Solid Tumor Progression: The Significant Contribution of Extracellular Vesicles. Stem Cells Int 2018;2018:6392198. [PMID: 30532788 DOI: 10.1155/2018/6392198] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
4 Scarpellino G, Genova T, Quarta E, Distasi C, Dionisi M, Fiorio Pla A, Munaron L. P2X Purinergic Receptors Are Multisensory Detectors for Micro-Environmental Stimuli That Control Migration of Tumoral Endothelium. Cancers (Basel) 2022;14:2743. [PMID: 35681724 DOI: 10.3390/cancers14112743] [Reference Citation Analysis]
5 Berg A, Fasmer KE, Mauland KK, Ytre-Hauge S, Hoivik EA, Husby JA, Tangen IL, Trovik J, Halle MK, Woie K, Bjørge L, Bjørnerud A, Salvesen HB, Werner HM, Krakstad C, Haldorsen IS. Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. Oncotarget 2016;7:69844-56. [PMID: 27634881 DOI: 10.18632/oncotarget.12004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
6 Ciavatta ML, Lefranc F, Carbone M, Mollo E, Gavagnin M, Betancourt T, Dasari R, Kornienko A, Kiss R. Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance. Med Res Rev 2017;37:702-801. [PMID: 27925266 DOI: 10.1002/med.21423] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
7 Ullmann P, Qureshi-Baig K, Rodriguez F, Ginolhac A, Nonnenmacher Y, Ternes D, Weiler J, Gäbler K, Bahlawane C, Hiller K, Haan S, Letellier E. Hypoxia-responsive miR-210 promotes self-renewal capacity of colon tumor-initiating cells by repressing ISCU and by inducing lactate production. Oncotarget 2016;7:65454-70. [PMID: 27589845 DOI: 10.18632/oncotarget.11772] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
8 Safari Yazd H, Yang Y, Li L, Yang L, Li X, Pan X, Chen Z, Jiang J, Cui C, Tan W. Precise Deposition of Polydopamine on Cancer Cell Membrane as Artificial Receptor for Targeted Drug Delivery. iScience 2020;23:101750. [PMID: 33367224 DOI: 10.1016/j.isci.2020.101750] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gu L, Zhang G, Zhang Y. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines. J Exp Clin Cancer Res 2019;38:269. [PMID: 31221196 DOI: 10.1186/s13046-019-1280-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
10 Dickreuter E, Cordes N. The cancer cell adhesion resistome: mechanisms, targeting and translational approaches. Biol Chem 2017;398:721-35. [PMID: 28002024 DOI: 10.1515/hsz-2016-0326] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
11 Wu P, Gao W, Su M, Nice EC, Zhang W, Lin J, Xie N. Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment. Front Cell Dev Biol 2021;9:641469. [PMID: 33732706 DOI: 10.3389/fcell.2021.641469] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
12 Zandberga E, Zayakin P, Ābols A, Pūpola D, Trapencieris P, Linē A. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells. Cancer Biol Ther 2017;18:596-605. [PMID: 28665755 DOI: 10.1080/15384047.2017.1345390] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhu H, Zhang L, Liu Y, Zhou Y, Wang K, Xie X, Song L, Wang D, Han C, Chen Q. Aptamer-PEG-modified Fe3O4@Mn as a novel T1- and T2- dual-model MRI contrast agent targeting hypoxia-induced cancer stem cells. Sci Rep 2016;6:39245. [PMID: 27976736 DOI: 10.1038/srep39245] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
14 Abou Khouzam R, Goutham HV, Zaarour RF, Chamseddine AN, Francis A, Buart S, Terry S, Chouaib S. Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy. Semin Cancer Biol 2020;65:140-54. [PMID: 31927131 DOI: 10.1016/j.semcancer.2020.01.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
15 Zhu G, Liu J, Wang Y, Jia N, Wang W, Zhang J, Liang Y, Tian H, Zhang J. ADAM17 Mediates Hypoxia-Induced Keratinocyte Migration via the p38/MAPK Pathway. Biomed Res Int 2021;2021:8328216. [PMID: 34746310 DOI: 10.1155/2021/8328216] [Reference Citation Analysis]
16 Newman M, Nik HM, Sutherland GT, Hin N, Kim WS, Halliday GM, Jayadev S, Smith C, Laird AS, Lucas CW, Kittipassorn T, Peet DJ, Lardelli M. Accelerated loss of hypoxia response in zebrafish with familial Alzheimer's disease-like mutation of presenilin 1. Hum Mol Genet 2020;29:2379-94. [PMID: 32588886 DOI: 10.1093/hmg/ddaa119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
17 Ruzzo A, Graziano F, Bagaloni I, Di Bartolomeo M, Prisciandaro M, Aprile G, Ongaro E, Vincenzi B, Perrone G, Santini D, Fornaro L, Vivaldi C, Tomasello G, Loupakis F, Lonardi S, Fassan M, Valmasoni M, Sarti D, Lorenzini P, Catalano V, Bisonni R, Del Prete M, Collina G, Magnani M. Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab. Gastric Cancer 2020;23:1064-74. [PMID: 32372141 DOI: 10.1007/s10120-020-01078-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kouidhi S, Noman MZ, Kieda C, Elgaaied AB, Chouaib S. Intrinsic and Tumor Microenvironment-Induced Metabolism Adaptations of T Cells and Impact on Their Differentiation and Function. Front Immunol 2016;7:114. [PMID: 27066006 DOI: 10.3389/fimmu.2016.00114] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
19 Voissiere A, Weber V, Gerard Y, Rédini F, Raes F, Chezal JM, Degoul F, Peyrode C, Miot-Noirault E. Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept. Oncotarget 2017;8:95824-40. [PMID: 29221170 DOI: 10.18632/oncotarget.21337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
20 Ashton J, Bristow R. Bad neighbours: hypoxia and genomic instability in prostate cancer. BJR 2020;93:20200087. [DOI: 10.1259/bjr.20200087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Wang C, Tao W, Ni S, Chen Q. SENP1 Interacts with HIF1α to Regulate Glycolysis of Prostatic Carcinoma Cells. Int J Biol Sci 2019;15:395-403. [PMID: 30745829 DOI: 10.7150/ijbs.27256] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
22 Laliani G, Ghasemian Sorboni S, Lari R, Yaghoubi A, Soleimanpour S, Khazaei M, Hasanian SM, Avan A. Bacteria and cancer: Different sides of the same coin. Life Sci 2020;246:117398. [PMID: 32032647 DOI: 10.1016/j.lfs.2020.117398] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
23 Zheng J, He S, Qi J, Wang X, Yu J, Wu Y, Gao Q, Wang K, Sun X. Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo. Int J Oncol 2017;51:478-88. [PMID: 28627695 DOI: 10.3892/ijo.2017.4040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
24 Żołnowska B, Sławiński J, Szafrański K, Angeli A, Supuran CT, Kawiak A, Wieczór M, Zielińska J, Bączek T, Bartoszewska S. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies. European Journal of Medicinal Chemistry 2018;143:1931-41. [DOI: 10.1016/j.ejmech.2017.11.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
25 Zhang L, He L, Lugano R, Roodakker K, Bergqvist M, Smits A, Dimberg A. IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas. Neuro Oncol 2018;20:1505-16. [PMID: 29846705 DOI: 10.1093/neuonc/noy088] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
26 Hashimoto R, Gupte S. Pentose Shunt, Glucose-6-Phosphate Dehydrogenase, NADPH Redox, and Stem Cells in Pulmonary Hypertension. Adv Exp Med Biol 2017;967:47-55. [PMID: 29047080 DOI: 10.1007/978-3-319-63245-2_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Yoon S, Rossi JJ. Targeted Molecular Imaging Using Aptamers in Cancer. Pharmaceuticals (Basel) 2018;11:E71. [PMID: 30029472 DOI: 10.3390/ph11030071] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
28 Lucien F, Pelletier PP, Lavoie RR, Lacroix JM, Roy S, Parent JL, Arsenault D, Harper K, Dubois CM. Hypoxia-induced mobilization of NHE6 to the plasma membrane triggers endosome hyperacidification and chemoresistance. Nat Commun 2017;8:15884. [PMID: 28635961 DOI: 10.1038/ncomms15884] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
29 Mal'tseva VN, Goltyaev MV, Turovsky EA, Varlamova EG. Immunomodulatory and Anti-Inflammatory Properties of Selenium-Containing Agents: Their Role in the Regulation of Defense Mechanisms against COVID-19. Int J Mol Sci 2022;23:2360. [PMID: 35216476 DOI: 10.3390/ijms23042360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Grossmann R, Schneider MA, Linecker M, Lehn JM, Nicolau C, Traber M, Tay F, Vicente D, Jetter A, Mollet A, Szucs T, Graf R, Clavien PA, Limani P. Interprofessional and interdisciplinary collaboration for early phase oncological clinical trials in academia-Myo-inositoltrispyrophophate as model. Pharmacol Res 2020;154:104238. [PMID: 31009662 DOI: 10.1016/j.phrs.2019.04.022] [Reference Citation Analysis]
31 Jahanban-Esfahlan R, de la Guardia M, Ahmadi D, Yousefi B. Modulating tumor hypoxia by nanomedicine for effective cancer therapy. J Cell Physiol 2018;233:2019-31. [PMID: 28198007 DOI: 10.1002/jcp.25859] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 20.0] [Reference Citation Analysis]
32 Stadlbauer A, Oberndorfer S, Heinz G, Zimmermann M, Kinfe TM, Doerfler A, Buchfelder M, Kremenevski N, Marhold F. Hypoxia and Microvascular Alterations Are Early Predictors of IDH-Mutated Anaplastic Glioma Recurrence. Cancers (Basel) 2021;13:1797. [PMID: 33918764 DOI: 10.3390/cancers13081797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Allam A, Yakou M, Pang L, Ernst M, Huynh J. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy. Front Immunol 2021;12:767939. [PMID: 34858425 DOI: 10.3389/fimmu.2021.767939] [Reference Citation Analysis]
34 Xia W, Shangguan X, Li M, Wang Y, Xi D, Sun W, Fan J, Shao K, Peng X. Ex vivo identification of circulating tumor cells in peripheral blood by fluorometric "turn on" aptamer nanoparticles. Chem Sci 2020;12:3314-21. [PMID: 34164101 DOI: 10.1039/d0sc05112h] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 De Francesco EM, Maggiolini M, Musti AM. Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT. Int J Mol Sci 2018;19:E2011. [PMID: 29996493 DOI: 10.3390/ijms19072011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 11.8] [Reference Citation Analysis]
36 Zakharia Y, Bhattacharya A, Rustum YM. Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development. Oncotarget 2018;9:10765-83. [PMID: 29535842 DOI: 10.18632/oncotarget.24297] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
37 Szymanska M, Manthe S, Shrestha K, Girsh E, Harlev A, Kisliouk T, Meidan R. Sirtuin-1 inhibits endothelin-2 expression in human granulosa-lutein cells via hypoxia inducible factor 1 alpha and epigenetic modifications†. Biol Reprod 2021;104:387-98. [PMID: 33112382 DOI: 10.1093/biolre/ioaa199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Roma-Rodrigues C, Mendes R, Baptista PV, Fernandes AR. Targeting Tumor Microenvironment for Cancer Therapy. Int J Mol Sci 2019;20:E840. [PMID: 30781344 DOI: 10.3390/ijms20040840] [Cited by in Crossref: 267] [Cited by in F6Publishing: 254] [Article Influence: 89.0] [Reference Citation Analysis]
39 Ding J, Mao Q, Zhao M, Gao Y, Wang A, Ye S, Wang X, Xie W, Shi H. Protein sulfenic acid-mediated anchoring of gold nanoparticles for enhanced CT imaging and radiotherapy of tumors in vivo. Nanoscale 2020;12:22963-9. [PMID: 33206090 DOI: 10.1039/d0nr06440h] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
40 Todeschini P, Salviato E, Romani C, Raimondi V, Ciccarese F, Ferrari F, Tognon G, Marchini S, D'Incalci M, Zanotti L, Ravaggi A, Odicino F, Sartori E, D'Agostino DM, Samaja M, Romualdi C, Bignotti E. Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer. Cancers (Basel) 2021;13:3358. [PMID: 34283087 DOI: 10.3390/cancers13133358] [Reference Citation Analysis]
41 Kieliszek M, Lipinski B, Błażejak S. Application of Sodium Selenite in the Prevention and Treatment of Cancers. Cells 2017;6:E39. [PMID: 29064404 DOI: 10.3390/cells6040039] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 9.8] [Reference Citation Analysis]
42 Baldominos P, Barbera-Mourelle A, Barreiro O, Huang Y, Wight A, Cho JW, Zhao X, Estivill G, Adam I, Sanchez X, McCarthy S, Schaller J, Khan Z, Ruzo A, Pastorello R, Richardson ET, Dillon D, Montero-Llopis P, Barroso-Sousa R, Forman J, Shukla SA, Tolaney SM, Mittendorf EA, von Andrian UH, Wucherpfennig KW, Hemberg M, Agudo J. Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche. Cell 2022;185:1694-1708.e19. [PMID: 35447074 DOI: 10.1016/j.cell.2022.03.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
43 Avanzato D, Genova T, Fiorio Pla A, Bernardini M, Bianco S, Bussolati B, Mancardi D, Giraudo E, Maione F, Cassoni P, Castellano I, Munaron L. Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling. Sci Rep 2016;6:32602. [PMID: 27586846 DOI: 10.1038/srep32602] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
44 Pöttler M, Cicha I, Lyer S, Janko C, Friedrich RP, Alexiou C. Journal watch: diagnostic nanoparticles. Nanomedicine (Lond) 2017;12:181-4. [PMID: 28093960 DOI: 10.2217/nnm-2016-0339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
45 Rivera Vargas T, Cai Z, Shen Y, Dosset M, Benoit-Lizon I, Martin T, Roussey A, Flavell RA, Ghiringhelli F, Apetoh L. Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells. Nat Commun 2017;8:559. [PMID: 28916785 DOI: 10.1038/s41467-017-00468-w] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
46 Saber SH, Ali HEA, Gaballa R, Gaballah M, Ali HI, Zerfaoui M, Abd Elmageed ZY. Exosomes are the Driving Force in Preparing the Soil for the Metastatic Seeds: Lessons from the Prostate Cancer. Cells 2020;9:E564. [PMID: 32121073 DOI: 10.3390/cells9030564] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
47 Corbin BA, Basal LA, White SA, Shen Y, Haacke EM, Fishbein KW, Allen MJ. Screening of ligands for redox-active europium using magnetic resonance imaging. Bioorg Med Chem 2018;26:5274-9. [PMID: 29653832 DOI: 10.1016/j.bmc.2018.04.001] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
48 Chen W, Dong J, Haiech J, Kilhoffer MC, Zeniou M. Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy. Stem Cells Int. 2016;2016:1740936. [PMID: 27418931 DOI: 10.1155/2016/1740936] [Cited by in Crossref: 130] [Cited by in F6Publishing: 155] [Article Influence: 21.7] [Reference Citation Analysis]
49 Terry S, Savagner P, Ortiz-Cuaran S, Mahjoubi L, Saintigny P, Thiery JP, Chouaib S. New insights into the role of EMT in tumor immune escape. Mol Oncol 2017;11:824-46. [PMID: 28614624 DOI: 10.1002/1878-0261.12093] [Cited by in Crossref: 145] [Cited by in F6Publishing: 140] [Article Influence: 29.0] [Reference Citation Analysis]
50 Limani P, Linecker M, Schneider MA, Kron P, Tschuor C, Kachaylo E, Ungethuem U, Nicolau C, Lehn JM, Graf R, Humar B, Clavien PA. The Allosteric Hemoglobin Effector ITPP Inhibits Metastatic Colon Cancer in Mice. Ann Surg 2017;266:746-53. [PMID: 28742687 DOI: 10.1097/SLA.0000000000002431] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
51 Zahan T, Das PK, Akter SF, Habib R, Rahman MH, Karim MR, Islam F. Therapy Resistance in Cancers: Phenotypic, Metabolic, Epigenetic and Tumour Microenvironmental Perspectives. Anticancer Agents Med Chem 2020;20:2190-206. [PMID: 32748758 DOI: 10.2174/1871520620999200730161829] [Reference Citation Analysis]
52 Colombani T, Eggermont LJ, Hatfield SM, Rogers ZJ, Rezaeeyazdi M, Memic A, Sitkovsky MV, Bencherif SA. Oxygen‐Generating Cryogels Restore T Cell Mediated Cytotoxicity in Hypoxic Tumors. Adv Funct Mater 2021;31:2102234. [DOI: 10.1002/adfm.202102234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
53 Napolitano A, Carbone M. Malignant Mesothelioma: Time to Translate? Trends Cancer 2016;2:467-74. [PMID: 28603777 DOI: 10.1016/j.trecan.2016.07.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
54 Terry S, Faouzi Zaarour R, Hassan Venkatesh G, Francis A, El-Sayed W, Buart S, Bravo P, Thiery J, Chouaib S. Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity. Int J Mol Sci 2018;19:E3044. [PMID: 30301213 DOI: 10.3390/ijms19103044] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 9.5] [Reference Citation Analysis]
55 Seo EJ, Kim DK, Jang IH, Choi EJ, Shin SH, Lee SI, Kwon SM, Kim KH, Suh DS, Kim JH. Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer. Oncotarget. 2016;7:55624-55638. [PMID: 27489349 DOI: 10.18632/oncotarget.10954] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 11.8] [Reference Citation Analysis]
56 Pajak B, Siwiak E, Sołtyka M, Priebe A, Zieliński R, Fokt I, Ziemniak M, Jaśkiewicz A, Borowski R, Domoradzki T, Priebe W. 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents. Int J Mol Sci 2019;21:E234. [PMID: 31905745 DOI: 10.3390/ijms21010234] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 14.0] [Reference Citation Analysis]
57 Liu D, Li H. Long non-coding RNA GEHT1 promoted the proliferation of ovarian cancer cells via modulating the protein stability of HIF1α. Biosci Rep 2019;39:BSR20181650. [PMID: 30988076 DOI: 10.1042/BSR20181650] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
58 Terry S, Buart S, Chouaib S. Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity. Front Immunol 2017;8:1625. [PMID: 29225600 DOI: 10.3389/fimmu.2017.01625] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
59 Jarman EJ, Ward C, Turnbull AK, Martinez-Perez C, Meehan J, Xintaropoulou C, Sims AH, Langdon SP. HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer. Breast Cancer Res 2019;21:10. [PMID: 30670058 DOI: 10.1186/s13058-019-1097-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
60 [DOI: 10.1101/2020.10.08.329805] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
61 Nunes SC. Tumor Microenvironment - Selective Pressures Boosting Cancer Progression. Adv Exp Med Biol 2020;1219:35-49. [PMID: 32130692 DOI: 10.1007/978-3-030-34025-4_2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
62 Baxevanis CN, Fortis SP, Perez SA. The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies. Semin Cancer Biol 2021;72:76-89. [PMID: 31881337 DOI: 10.1016/j.semcancer.2019.12.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
63 Coppes R, Dubrovska A. Targeting Stem Cells in Radiation Oncology. Clinical Oncology 2017;29:329-34. [DOI: 10.1016/j.clon.2017.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
64 Fiorese CJ, Haynes CM. Integrating the UPRmt into the mitochondrial maintenance network. Crit Rev Biochem Mol Biol 2017;52:304-13. [PMID: 28276702 DOI: 10.1080/10409238.2017.1291577] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
65 Woolbright BL, Ayres M, Taylor JA. Metabolic changes in bladder cancer. Urologic Oncology: Seminars and Original Investigations 2018;36:327-37. [DOI: 10.1016/j.urolonc.2018.04.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
66 Engel C, Brügmann G, Lambing S, Mühlenbeck LH, Marx S, Hagen C, Horváth D, Goldeck M, Ludwig J, Herzner AM, Drijfhout JW, Wenzel D, Coch C, Tüting T, Schlee M, Hornung V, Hartmann G, Van den Boorn JG. RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation. Cancer Immunol Res 2017;5:455-67. [PMID: 28468914 DOI: 10.1158/2326-6066.CIR-16-0129-T] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]